Immunomodulatory properties of human adult and fetal multipotent mesenchymal stem cells
about
Advances in the Treatment of Ischemic Diseases by Mesenchymal Stem CellsMultipotent mesenchymal stromal cells: A promising strategy to manage alcoholic liver diseaseUpdate on mesenchymal stem cell-based therapy in lupus and sclerodermaConcise review: bone marrow autotransplants for liver disease?Progress of mesenchymal stem cell therapy for neural and retinal diseasesHuman mesenchymal stem cells (MSCs) for treatment towards immune- and inflammation-mediated diseases: review of current clinical trialsCharacterization and profiling of immunomodulatory genes of equine mesenchymal stromal cells from non-invasive sources.Comparative analysis of multilineage properties of mesenchymal stromal cells derived from fetal sources shows an advantage of mesenchymal stromal cells isolated from cord blood in chondrogenic differentiation potentialDifferent culture conditions modulate the immunological properties of adipose stem cells.Mesenchymal stem cells from fetal heart attenuate myocardial injury after infarction: an in vivo serial pinhole gated SPECT-CT study in ratsToll like receptor 3 & 4 responses of human turbinate derived mesenchymal stem cells: stimulation by double stranded RNA and lipopolysaccharideEffect of human bone marrow mesenchymal stromal cells on cytokine production by peripheral blood naive, memory, and effector T cells.Comparative Ability of Mesenchymal Stromal Cells from Different Tissues to Limit Neutrophil Recruitment to Inflamed EndotheliumInterleukin-25 Mediates Transcriptional Control of PD-L1 via STAT3 in Multipotent Human Mesenchymal Stromal Cells (hMSCs) to Suppress Th17 Responses.Integrated transcriptomic and proteomic analysis of the molecular cargo of extracellular vesicles derived from porcine adipose tissue-derived mesenchymal stem cellsThe Role of Cathelicidin LL-37 in Cancer Development.Comparative Evaluation of Human Mesenchymal Stem Cells of Fetal (Wharton's Jelly) and Adult (Adipose Tissue) Origin during Prolonged In Vitro Expansion: Considerations for CytotherapyCell therapy for full-thickness wounds: are fetal dermal cells a potential source?A New Method for Preparing Mesenchymal Stem Cells and Labeling with Ferumoxytol for Cell Tracking by MRIDickkopf-1 has an Inhibitory Effect on Mesenchymal Stem Cells to Fibroblast Differentiation.The Necessity of a Systematic Approach for the Use of MSCs in the Clinical SettingSubretinal adipose tissue-derived mesenchymal stem cell implantation in advanced stage retinitis pigmentosa: a phase I clinical safety study.Progenitor cells for ocular surface regenerative therapy.Perspectives on the use of stem cells for autism treatmentDNA Methylation Changes during In Vitro Propagation of Human Mesenchymal Stem Cells: Implications for Their Genomic Stability?Amniotic membrane-derived stem cells: immunomodulatory properties and potential clinical application.Immunomodulation in stem cell differentiation into neurons and brain repair.Cell-based therapeutic strategies for replacement and preservation in retinal degenerative diseases.Human bone marrow stromal cells lose immunosuppressive and anti-inflammatory properties upon oncogenic transformation.Mesenchymal Stem Cell Treatment of Inflammation-Induced Cancer.Molecular and Cellular Interactions of Allogenic and Autologus Mesenchymal Stem Cells with Innate and Acquired Immunity and Their Role in Regenerative Medicine.Isolation, expansion and characterisation of mesenchymal stem cells from human bone marrow, adipose tissue, umbilical cord blood and matrix: a comparative study.Sustained benefit from combined plasmapheresis and allogeneic mesenchymal stem cells transplantation therapy in systemic sclerosis.Efficacy of fetal stem cell transplantation in autism spectrum disorders: an open-labeled pilot study.Positron emission tomography-computer tomography scan used as a monitoring tool following cellular therapy in cerebral palsy and mental retardation-a case report.Clonal populations of amniotic cells by dilution and direct plating: evidence for hidden diversity.Comparison of proliferative and multilineage differentiation potential of sheep mesenchymal stem cells derived from bone marrow, liver, and adipose tissueAutologous stromal vascular fraction therapy for rheumatoid arthritis: rationale and clinical safety.Mesenchymal stem cells from umbilical cord matrix, adipose tissue and bone marrow exhibit different capability to suppress peripheral blood B, natural killer and T cells.EphB and Ephrin-B interactions mediate human mesenchymal stem cell suppression of activated T-cells.
P2860
Q26746977-F280714F-7E5E-4E83-B920-880F0284A33DQ26769618-D0C7C7F1-E815-4861-86F6-CFAD3984E120Q26777402-3CB11995-DB72-4EF0-8029-133F0D9A8F17Q27010009-CDF4AF8D-605B-4976-9386-C5A4AF153C78Q27015716-233EF91C-F857-48B8-8B25-AD6FC9DD9B65Q28071916-9ABA3BAC-2C88-4BB6-BEEE-BC0D5E54F422Q33746529-345D15D2-F0D0-41A3-9D28-56B3F58270CAQ33775712-3A069133-172C-4F0B-B427-E443B7BC0E9BQ34273076-6BA15838-2AF4-4A84-8D17-980EDC916C1CQ35196281-8246E5BF-E4F1-41C4-A1C7-6CFE3202629CQ35203177-8BEC36A0-A274-4C25-AD1E-9E6936A76049Q35562203-CB6ED49A-0DAC-459F-96C6-EB2781599E77Q36015654-52FA4E81-1526-4D34-B486-BF8839454004Q36201380-6C98417F-DC99-492E-BF38-EA8204FD4E9BQ36319925-2478FABB-D1D3-4996-977F-79956163E326Q36465085-0689BA86-928B-4F2E-B8A5-DE827CEDC8E6Q36702970-B0048D1C-4E5E-4FB4-A977-B2B9C9C0BA2BQ36762289-EB3F53DA-1756-4970-9EB6-A0F0611E042DQ36911124-427CD158-5FFD-4EB3-ACFD-FABBF778F358Q36930148-37455C97-1B7D-4120-A8F4-8724C10C5AE5Q36995514-A859C176-C42D-4DF2-952D-E49E23B1E62BQ37466512-13597872-DFE6-479C-AEF3-1BD482B87038Q38069060-182E185C-7EC0-47DF-B488-2D0680C1A639Q38162181-3947B102-C7C9-460E-8FA9-194B3B85F095Q38167313-631C0A9F-1EED-4696-AA43-4237176F80ACQ38205430-82D1D70D-C0A8-43E4-8462-5077CF16C34FQ38255419-DFA853D9-C316-497E-9976-F9D194772012Q38767261-10630D64-23D8-4B6D-B7BE-DDBD4104D9EDQ38943709-2A92C729-7312-4D51-B68A-6A110BA693A3Q38983878-82A8BCDF-EE91-43A7-8C4B-5F0CE7249669Q39175513-3E2F91C7-6AF0-468F-97FE-49E4B99E53C0Q39198131-0731B0E1-483F-45D8-9268-6DB799139BD2Q41066068-1C72E9B8-8477-41C0-8859-D0BCC85BE2E9Q41706699-56D8A4C7-2765-4F0D-9FC8-160FA8DB7F25Q41898034-D67D399F-8CA2-4D74-AD78-4BD8C70829C6Q42045184-A63C7646-E36B-4D79-A012-21BAAD953BB3Q42573535-524C1086-B78A-4F84-9CAC-4DB2686C60C6Q42593149-A21B471E-0E11-4537-9BFF-238B060F52F2Q42636758-014FBDAE-02F8-46DB-B901-FF6FF0CD6A1DQ42962199-3B3D37AE-3536-4A66-93C4-8FA6F8782CF1
P2860
Immunomodulatory properties of human adult and fetal multipotent mesenchymal stem cells
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Immunomodulatory properties of human adult and fetal multipotent mesenchymal stem cells
@ast
Immunomodulatory properties of human adult and fetal multipotent mesenchymal stem cells
@en
type
label
Immunomodulatory properties of human adult and fetal multipotent mesenchymal stem cells
@ast
Immunomodulatory properties of human adult and fetal multipotent mesenchymal stem cells
@en
prefLabel
Immunomodulatory properties of human adult and fetal multipotent mesenchymal stem cells
@ast
Immunomodulatory properties of human adult and fetal multipotent mesenchymal stem cells
@en
P2093
P2860
P921
P356
P1476
Immunomodulatory properties of human adult and fetal multipotent mesenchymal stem cells
@en
P2093
B-Linju Yen
Huey-Kang Sytwu
Ko-Jiunn Liu
Men-Luh Yen
Pei-Min Chen
P2860
P2888
P356
10.1186/1423-0127-18-49
P577
2011-07-18T00:00:00Z
P5875
P6179
1049720439